Pleiotropic Roles for ZEB1 in Cancer

被引:262
|
作者
Caramel, Julie [1 ,2 ]
Ligier, Maud [1 ,2 ]
Puisieux, Alain [1 ,2 ]
机构
[1] Univ Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Ctr Leon Berard,Canc Res Ctr Lyon,Equipe Labellis, Lyon, France
[2] Univ Lyon, LabEx DEVweCAN, Lyon, France
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; EMT-ACTIVATOR ZEB1; TRANSCRIPTION FACTORS; DRUG-RESISTANCE; CELL PLASTICITY; STEM-CELLS; PANCREATIC-CANCER; OVARIAN-CANCER; LUNG-CANCER; METASTASIS;
D O I
10.1158/0008-5472.CAN-17-2476
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ZEB1 is a prime element of a network of transcription factors that controls epithelial-to-mesenchymal transition (EMT), a reversible embryonic transdifferentiation program that allows partial or complete transition from an epithelial to a mesenchymal state. Aberrant expression of ZEB1 has been reported in a variety of human cancers, where it is generally believed to foster migration, invasion, and metastasis. Over the past few years, in vitro and in vivo observations have highlighted unsuspected intrinsic oncogenic functions of ZEB1 that impact tumorigenesis from its earliest stages. Located downstream of regulatory processes that integrate microenvironmental signals and directly implicated in feedback loops controlled by miRNAs, ZEB1 appears to be a central switch that determines cell fate. Its expression fosters malignant transformation through the mitigation of critical oncosuppressive pathways and through the conferment of stemness properties. ZEB1 is also a key determinant of cell plasticity, endowing cells with the capacity to withstand an aberrant mitogenic activity, with a profound impact on the genetic history of tumorigenesis, and to adapt to the multiple constraints encountered over the course of tumor development. (C) 2017 AACR.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 50 条
  • [21] The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer
    Nancy Farfán
    Nallatt Ocarez
    Enrique A. Castellón
    Nilo Mejía
    Antonio García de Herreros
    Héctor R. Contreras
    Scientific Reports, 8
  • [22] Expression and Function of ZEB1 in the Cornea
    Zhang, Yingnan
    Liu, Xiao
    Liang, Wei
    Dean, Douglas C.
    Zhang, Lijun
    Liu, Yongqing
    CELLS, 2021, 10 (04)
  • [23] Suppression of SDC-1 expression by overexpression of ZEB1/ZEB2 in prostate cancer cells
    Contreras, H.
    Farfan, N.
    Orellana-Serradell, O.
    Chrzanowsky, D.
    Castellon, E.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S26 - S26
  • [24] The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer
    Farfan, Nancy
    Ocarez, Nallatt
    Castellon, Enrique A.
    Mejia, Nilo
    Garcia de Herreros, Antonio
    Contreras, Hector R.
    SCIENTIFIC REPORTS, 2018, 8
  • [25] ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM
    Zhang, Xiang
    Zhang, Zhen
    Zhang, Qing
    Zhang, Quansheng
    Sun, Peiqing
    Xiang, Rong
    Ren, Guosheng
    Yang, Shuang
    CELL DEATH & DISEASE, 2018, 9
  • [26] E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
    Otto Schmalhofer
    Simone Brabletz
    Thomas Brabletz
    Cancer and Metastasis Reviews, 2009, 28 : 151 - 166
  • [27] Elucidating the role of ZEB1 in metastatic castration resistant prostate cancer
    Sweeney, Katrina
    Stylianou, Nataly
    Fazli, Ladan
    Tevz, Gregor
    Pirlo, Katrina
    Upadhyaya, Akanksha
    Ratther, Ellca
    Lehman, Melanie
    Gleave, Martin
    Gunter, Jennifer
    Williams, Elizabeth D.
    Nelson, Colleen C.
    Hollier, Brett
    BJU INTERNATIONAL, 2016, 118 : 23 - 24
  • [28] Vasoactive intestinal polypeptide (VIP) regulates ZEB1 expression in cancer
    Rao, Ishani H.
    Dhamsania, Rohan
    Waller, Edmund K.
    Chandrasekaran, Sanjay
    CANCER RESEARCH, 2022, 82 (12)
  • [29] Elucidating the role of ZEB1 in metastatic castration resistant prostate cancer
    Sweeney, Katrina
    Stylianou, Nataly
    Tevz, Gregor
    Pirlo, Katrina
    Upadhyaya, Akanksha
    Lehman, Melanie
    Fazli, Ladan
    Gleave, Martin
    Gunter, Jennifer
    Williams, Elizabeth D.
    Nelson, Colleen C.
    Hollier, Brett G.
    BJU INTERNATIONAL, 2015, 116 : 35 - 35
  • [30] ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer
    Irene Fernandez-De-Los-Reyes
    Marisa Gomez-Dorronsoro
    Iñaki Monreal-Santesteban
    Agustín Fernandez-Fernandez
    Mario Fraga
    Pablo Azcue
    Laura Alonso
    Beatriz Fernandez-Marlasca
    Javier Suarez
    Alicia Cordoba-Iturriagagoitia
    David Guerrero-Setas
    Clinical Epigenetics, 15